These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 14527310)

  • 1. Structural, functional, and molecular MR imaging of the microvasculature.
    Neeman M; Dafni H
    Annu Rev Biomed Eng; 2003; 5():29-56. PubMed ID: 14527310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic contrast-enhanced magnetic resonance imaging for assessing tumor vascularity and vascular effects of targeted therapies in renal cell carcinoma.
    Rosen MA; Schnall MD
    Clin Cancer Res; 2007 Jan; 13(2 Pt 2):770s-776s. PubMed ID: 17255308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional and molecular MR imaging of angiogenesis: seeing the target, seeing it work.
    Neeman M
    J Cell Biochem Suppl; 2002; 39():11-7. PubMed ID: 12552597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and molecular detection of atherothrombosis by magnetic resonance--potential tools for individual risk assessment and diagnostics.
    Ala-Korpela M; Sipola P; Kaski K
    Ann Med; 2006; 38(5):322-36. PubMed ID: 16938802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic contrast-enhanced magnetic resonance imaging and blood oxygenation level-dependent magnetic resonance imaging for the assessment of changes in tumor biology with treatment.
    Li SP; Padhani AR; Makris A
    J Natl Cancer Inst Monogr; 2011; 2011(43):103-7. PubMed ID: 22043053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging.
    Wilmes LJ; Pallavicini MG; Fleming LM; Gibbs J; Wang D; Li KL; Partridge SC; Henry RG; Shalinsky DR; Hu-Lowe D; Park JW; McShane TM; Lu Y; Brasch RC; Hylton NM
    Magn Reson Imaging; 2007 Apr; 25(3):319-27. PubMed ID: 17371720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular imaging of angiogenesis.
    Neeman M; Gilad AA; Dafni H; Cohen B
    J Magn Reson Imaging; 2007 Jan; 25(1):1-12. PubMed ID: 17139635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion, perfusion and functional magnetic resonance imaging.
    Le Bihan D
    J Mal Vasc; 1995; 20(3):203-14. PubMed ID: 8543902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha(nu)beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging.
    Winter PM; Caruthers SD; Kassner A; Harris TD; Chinen LK; Allen JS; Lacy EK; Zhang H; Robertson JD; Wickline SA; Lanza GM
    Cancer Res; 2003 Sep; 63(18):5838-43. PubMed ID: 14522907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis.
    Oto A; Yang C; Kayhan A; Tretiakova M; Antic T; Schmid-Tannwald C; Eggener S; Karczmar GS; Stadler WM
    AJR Am J Roentgenol; 2011 Dec; 197(6):1382-90. PubMed ID: 22109293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of blood volume, vessel size, and the expression of angiogenic factors in two rat glioma models: a longitudinal in vivo and ex vivo study.
    Valable S; Lemasson B; Farion R; Beaumont M; Segebarth C; Remy C; Barbier EL
    NMR Biomed; 2008 Nov; 21(10):1043-56. PubMed ID: 18615861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inter-reader agreement of multi-parametric MR imaging for the detection of prostate cancer: evaluation of a scoring system.
    Quentin M; Arsov C; Röhlen S; Klasen J; Antoch G; Albers P; Blondin D
    Rofo; 2012 Oct; 184(10):925-9. PubMed ID: 22744328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor angiogenesis: pathophysiology and implications for contrast-enhanced MRI and CT assessment.
    Cuenod CA; Fournier L; Balvay D; Guinebretière JM
    Abdom Imaging; 2006; 31(2):188-93. PubMed ID: 16447089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging.
    Choyke PL; Dwyer AJ; Knopp MV
    J Magn Reson Imaging; 2003 May; 17(5):509-20. PubMed ID: 12720260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vessel growth and function: depiction with contrast-enhanced MR imaging.
    Oostendorp M; Post MJ; Backes WH
    Radiology; 2009 May; 251(2):317-35. PubMed ID: 19401568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [3 Tesla magnetic resonance imaging of the brain. Better morphological and functional images with higher magnetic field strength].
    Larsson EM; Ståhlberg F
    Lakartidningen; 2005 Feb 14-20; 102(7):460-3. PubMed ID: 15768694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress in magnetic resonance imaging of brain tumours.
    Lemort M; Canizares-Perez AC; Van der Stappen A; Kampouridis S
    Curr Opin Oncol; 2007 Nov; 19(6):616-22. PubMed ID: 17906462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging tumor angiogenesis: functional assessment using MDCT or MRI?
    Goh V; Padhani AR
    Abdom Imaging; 2006; 31(2):194-9. PubMed ID: 16333695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic contrast enhanced (DCE) magnetic resonance imaging (MRI) of atherosclerotic plaque angiogenesis.
    Calcagno C; Mani V; Ramachandran S; Fayad ZA
    Angiogenesis; 2010 Jun; 13(2):87-99. PubMed ID: 20526859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Magnetic resonance imaging-guided endovascular interventions].
    Wacker FK; Bock M
    Rofo; 2007 Apr; 179(4):355-64. PubMed ID: 17385130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.